Biocon 配当と自社株買い
配当金 基準チェック /26
Biocon配当を支払う会社であり、現在の利回りは0.15%で、収益によって十分にカバーされています。
主要情報
0.2%
配当利回り
-0.03%
バイバック利回り
| 総株主利回り | 0.1% |
| 将来の配当利回り | 0.7% |
| 配当成長 | -23.8% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | ₹0.500 |
| 配当性向 | 6% |
最近の配当と自社株買いの更新
Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50
Jun 11
Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50
May 23Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50
Jul 03Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50
May 26Recent updates
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results
Nov 02Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E
Nov 01Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?
Oct 14These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Sep 20Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors
Jun 29Is Biocon (NSE:BIOCON) A Risky Investment?
Jun 11Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50
Jun 11Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations
May 24Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50
May 23Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?
Mar 20Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next
Feb 12Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price
Jan 23Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price
Jan 03These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Nov 13Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)
Aug 03Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50
Jul 03Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 02Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50
May 26Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)
Mar 28Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly
Feb 26Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate
Dec 17Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?
Sep 05Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 13Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate
May 26決済の安定と成長
配当データの取得
安定した配当: BIOCONの配当金支払いは、過去10年間 変動性 が高かった。
増加する配当: BIOCONの配当金支払額は過去10年間減少しています。
配当利回り対市場
| Biocon 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (BIOCON) | 0.2% |
| 市場下位25% (IN) | 0.3% |
| 市場トップ25% (IN) | 1.2% |
| 業界平均 (Biotechs) | 1.1% |
| アナリスト予想 (BIOCON) (最長3年) | 0.7% |
注目すべき配当: BIOCONの配当金 ( 0.15% ) はIndian市場の配当金支払者の下位 25% ( 0.25% ) と比べると目立ったものではありません。
高配当: BIOCONの配当金 ( 0.15% ) はIndian市場の配当金支払者の上位 25% ( 1.15% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: BIOCONの配当性向は低く ( 5.8% )、配当金は利益によって十分にカバーされています。
株主配当金
キャッシュフローカバレッジ: BIOCONは 現金配当性向 ( 2.8% ) が低いため、配当金の支払いはキャッシュフローによって完全にカバーされています。